Table 1.
Variables | Normal Weight (n = 48 Patients) |
Overweight (n = 33 Patients) |
Obese (n = 14 Patients) |
p-Value |
---|---|---|---|---|
Patients | 48 (50.5%) | 33 (34.7%) | 14 (14.7%) | - |
Height (cm) | 171 ± 8 | 168 ± 8 | 168 ± 10 | 0.097 |
Weight (kg) | 66 ± 8 | 76 ± 8 | 99 ± 12 | <0.01 |
Gender | 0.89 | |||
Male | 26 (54.2%) | 19 (57.6%) | 7 (50%) | |
Female | 22 (45.8%) | 14 (42.4%) | 7 (50%) | |
Age (years) | 62.1 ± 1.7 | 64.9 ± 1.5 | 61.3 ± 2.5 | 0.39 |
ASA, score (%) | <0.01 | |||
1–2 | 39 (82%) | 23 (70%) | 5 (36%) | |
3–4 | 9 (18%) | 10 (30%) | 9 (64%) | |
Diabetes mellitus | 0.21 | |||
Yes | 13 (27.1%) | 8 (24.2%) | 6 (42.9%) | |
No | 34 (70.8) | 22 (66.7%) | 6 (42.9%) | |
Missing | 1 (2.1%) | 3 (9.1%) | 2 (14.2%) | |
Cirrhosis/Fibrosis | 0.91 | |||
Yes | 5 (10.4%) | 4 (12.1%) | 2 (14.3%) | |
No | 43 (89.6%) | 29 (87.9%) | 12 (85.7%) | |
Clinical Jaundice | 0.79 | |||
Yes | 38 (79.1%) | 27 (81.8%) | 10 (71.4%) | |
No | 10 (20.9%) | 6 (18.2%) | 4 (28.6%) | |
CA 19-9, (U/L) | 292.7 ± 101.6 | 340.2 ± 582.5 | 338.6 ± 669 | 0.89 |
CEA, (ng/mL) | 6.2 ± 2.3 | 2.8 ± 0.8 | 2.1 ± 0.6 | 0.31 |
Peak Bilirubin preoperative (ummol/L) | 44.1 ± 6.8 | 70.8 ± 15.4 | 33.9 ± 13.1 | 0.11 |
Preoperative drainage | 0.29 | |||
No | 7 (14.6%) | 6 (18.2%) | 4 (28.6%) | |
PTCD | 7 (14.6%) | 2 (6.1%) | 0 (0%) | |
ERCP | 33 (68.8%) | 20 (60.6%) | 8 (57.1%) | |
Both | 0 (0%) | 2 (6.1%) | 1 (7.1%) | |
Missing | 1 (2.1%) | 3 (9.1%) | 1 (7.1%) | |
Portal vein involvement on imaging | 0.693 | |||
Yes | 12 (25%) | 8 (24.2) | 2 (14.3) | |
No | 36 (75%) | 25 (75.8) | 12 (85.7) | |
Bismuth-Corlette classification | 0.64 | |||
I | 2 (4.2%) | 2 (6.1%) | 2 (14.3%) | |
II | 4 (8.3%) | 2 (6.1%) | 2 (14.3%) | |
IIIa | 6 (12.5%) | 4 (12.1%) | 1 (7.1%) | |
IIIb | 7 (14.6%) | 3 (9.1%) | 2 (14.3%) | |
IV | 25 (52.1%) | 20 (60.6%) | 4 (28.6%) | |
Missing | 4 (8.3%) | 2 (6.1%) | 3 (21.4) |